Aehr Test Systems AEHR NASDAQ

NASDAQ Capital Marke • Technology • Semiconductors • US • USD

SharesGrow Score

53/100

2/7 Pass

SharesGrow Intrinsic Value

Income Statement Balance Sheet Cash Flow Statement

Annual Quarterly

Aehr Test Systems (AEHR) generated $-7.4M in operating cash flow for fiscal year 2025. After capital expenditures of $4.99M, free cash flow was $-12.39M.

Free cash flow margin was -21% of revenue. Cash conversion ratio was 1.89x, indicating earnings are backed by cash.

The company returned $784K in share buybacks to shareholders during the period.

Criteria supported by this page:

HEALTH (100/100, Pass) — demonstrate the company can comfortably service its debt
MOAT (40/100, Fail) — limited free cash flow weakens the competitive position
INCOME (10/100) — Cash conversion ratio was 1.89x confirms earnings are backed by real cash flow

Overall SharesGrow Score: 53/100 with 2/7 criteria passed.

SharesGrow 7-Criteria Score

53/100

SG Score

View full scorecard →

VALUE

49/100

Price-to-Earnings & upside

→ Valuation

✗

FUTURE

16/100

Analyst consensus

→ Forecast

PAST

75/100

→ Income

✓

HEALTH

100/100

Debt-to-Equity & liquidity

Proven by this page

✗

MOAT

40/100

Proven by this page

✓

GROWTH

83/100

→ Income

✗

INCOME

10/100

→ Income

Aehr Test Systems Cash Flow History

Metric	TTM	FY2025	FY2024	FY2023	FY2022
Operating Cash Flow	$-7.44M	$-7.4M	$1.76M	$10.01M	$1.51M
Capital Expenditure	$-4.75M	$-4.99M	$-749K	$-1.36M	$-416K
Free Cash Flow	$-12.19M	$-12.39M	$1.01M	$8.65M	$1.09M